Physician profile
Twinkle Singh
NPI 1235545757
$22,851.26
in general payments reported to CMS, 2019-2025
34 companies · $580 in 2025
The $580 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $3,161 · 2021: $6,243 · 2022: $6,732 · 2023: $4,678 · 2024: $747 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,024 · Food and Beverage: $2,982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,023.56 |
| Food and Beverage | $2,981.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,359.57 | 2020-2025 | Optis, Pressurewire, Diamondback Coronary |
| Shockwave Medical, INC | $2,224.49 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $1,994.97 | 2020-2025 | Indigo System |
| Medtronic, INC. | $1,235.86 | 2021-2025 | Linq II, Micra, Symplicity G3 |
| Terumo Medical Corporation | $904.39 | 2019-2025 | Metacross Otw, R2p Misago, Azur Cx Detachable |
| Cardiovascular Systems INC. | $877.44 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $872.11 | 2019-2025 | |
| Biotronik INC. | $823.78 | 2020-2022 | |
| Boston Scientific Corporation | $816.37 | 2020-2025 | Farapulse, Ekosonic |
| Bard Peripheral Vascular, INC. | $559.53 | 2021-2022 | |
| Abiomed | $521.97 | 2019-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $463.70 | 2019-2024 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $434.59 | 2020-2025 | Lifevest |
| Chiesi USA, INC. | $353.37 | 2020-2024 | Kengreal, Cleviprex |
| Astrazeneca Pharmaceuticals LP | $339.14 | 2019-2023 | Andexxa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $304.67 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $231.81 | 2019-2024 | Opsumit, Uptravi |
| Cordis US Corp. | $179.75 | 2021-2022 | |
| Teleflex LLC | $148.98 | 2022-2024 | Turnpike |
| Amgen INC. | $125.45 | 2022 | |
| Philips North America LLC | $125.39 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $124.56 | 2019 | |
| United Therapeutics Corporation | $119.78 | 2019 | |
| Cook Medical LLC | $114.72 | 2019-2022 | |
| Cardiva Medical, INC. | $111.03 | 2020-2021 | |
| Cagent Vascular INC | $106.46 | 2022 | |
| Heartflow, INC. | $105.54 | 2020 | |
| Cardinal Health 200 LLC | $55.28 | 2020-2021 | |
| Biosense Webster, INC. | $54.71 | 2024 | Carto 3 |
| Alnylam Pharmaceuticals INC. | $48.84 | 2025 | Onpattro |
| Merck Sharp & Dohme LLC | $41.03 | 2023-2024 | Verquvo |
| Getinge USA Sales, LLC | $38.10 | 2020 | |
| Asahi Intecc USA, INC. | $22.20 | 2022 | |
| Abbvie INC. | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Twinkle Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.